Clearbridge Health Ltd

SGX:1H3 (Singapore)  
S$ 0.01 (+9.09%) Jun 21
At Loss
P/B:
0.75
Market Cap:
S$ 7.44M ($ 5.49M)
Enterprise V:
S$ 10.59M ($ 7.81M)
Volume:
2.67M
Avg Vol (2M):
1.35M
Trade In:
Volume:
2.67M
At Loss
Avg Vol (2M):
1.35M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Clearbridge Health Ltd ( ) from 2017 to Jun 23 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Clearbridge Health stock (SGX:1H3) PE ratio as of Jun 23 2024 is 0. More Details

Clearbridge Health Ltd (SGX:1H3) PE Ratio (TTM) Chart

To

Clearbridge Health Ltd (SGX:1H3) PE Ratio (TTM) Historical Data

Total 1272
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
Clearbridge Health PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-24 At Loss 2024-04-18 At Loss
2024-06-21 At Loss 2024-04-17 At Loss
2024-06-20 At Loss 2024-04-16 At Loss
2024-06-19 At Loss 2024-04-15 At Loss
2024-06-18 At Loss 2024-04-12 At Loss
2024-06-14 At Loss 2024-04-11 At Loss
2024-06-13 At Loss 2024-04-10 At Loss
2024-06-12 At Loss 2024-04-09 At Loss
2024-06-11 At Loss 2024-04-08 At Loss
2024-06-10 At Loss 2024-04-05 At Loss
2024-06-07 At Loss 2024-04-04 At Loss
2024-06-06 At Loss 2024-04-03 At Loss
2024-06-05 At Loss 2024-04-02 At Loss
2024-06-04 At Loss 2024-04-01 At Loss
2024-06-03 At Loss 2024-03-29 At Loss
2024-05-31 At Loss 2024-03-28 At Loss
2024-05-30 At Loss 2024-03-27 At Loss
2024-05-29 At Loss 2024-03-26 At Loss
2024-05-28 At Loss 2024-03-25 At Loss
2024-05-27 At Loss 2024-03-22 At Loss
2024-05-24 At Loss 2024-03-21 At Loss
2024-05-23 At Loss 2024-03-20 At Loss
2024-05-21 At Loss 2024-03-19 At Loss
2024-05-20 At Loss 2024-03-18 At Loss
2024-05-17 At Loss 2024-03-15 At Loss
2024-05-16 At Loss 2024-03-14 At Loss
2024-05-15 At Loss 2024-03-13 At Loss
2024-05-14 At Loss 2024-03-12 At Loss
2024-05-13 At Loss 2024-03-11 At Loss
2024-05-10 At Loss 2024-03-08 At Loss
2024-05-09 At Loss 2024-03-07 At Loss
2024-05-08 At Loss 2024-03-06 At Loss
2024-05-07 At Loss 2024-03-05 At Loss
2024-05-06 At Loss 2024-03-04 At Loss
2024-05-03 At Loss 2024-03-01 At Loss
2024-05-02 At Loss 2024-02-29 At Loss
2024-05-01 At Loss 2024-02-28 At Loss
2024-04-30 At Loss 2024-02-27 At Loss
2024-04-29 At Loss 2024-02-26 At Loss
2024-04-26 At Loss 2024-02-23 At Loss
2024-04-25 At Loss 2024-02-22 At Loss
2024-04-24 At Loss 2024-02-21 At Loss
2024-04-23 At Loss 2024-02-20 At Loss
2024-04-22 At Loss 2024-02-19 At Loss
2024-04-19 At Loss 2024-02-16 At Loss

Clearbridge Health Ltd (SGX:1H3) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Clearbridge Health Ltd provides health care services. It is an integrated healthcare group with end-to-end diagnostic abilities, deploying non-invasive tests to identify and manage illness. The segments are Strategic investments; Healthcare systems; Medical clinics; Corporate segment and Investment. It derives key revenue from the Healthcare systems and Medical clinics. The Healthcare systems segment involves, the provision of diagnostic services manufacturing of and research and development on diagnostic-related products, and provision of renal care services by partnering with medical device equipment manufacturers and hospitals. The Medical clinics segment involves, the provision of general medical and clinical services. The group has a business presence all over the world.